Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides

International Journal of Dairy Technology

Volumn 57, Issue 2-3, 2004, Pages 173-188

  Gobbetti, Marco ^a   Minervini, Fabio ^a   Rizzello, Carlo G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

ACE inhibitory peptides; Antimicrobial peptides; Bioactive peptides; Lactic acid bacteria; Lactobacillus helveticus; Milk proteins

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MILK PROTEIN; PEPTIDE;

ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; DIET; FOOD MICROBIOTECHNOLOGY; LACTIC ACID BACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS HELVETICUS;

EID: 2442700132     PISSN: 1364727X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0307.2004.00139.x     Document Type: Conference Paper

References (101)

1. Bechinger B (1997) Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. Journal of Membrane Biology 156 197-211.
2. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K and Tomita M (1992) Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta 1121 130-136.
3. Bernard H, Meisel H, Creminon C and Wal J M (2000) Post-translational phosphorylation affects the IgE binding activity of caseins. FEBS Letters 467 239-244.
4. Blondelle S E and Lohner K (2000) Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55 74-87.
5. Brantl V, Teschemacher H, Bläsig J, Henschen A and Lottspeich F (1981) Opioid activities of β-casomorphins. Life Science 28 1903-1909.
6. Calder P C (1994) Glutamine and the immune system. Clinical Nutrition 13 2-8.
7. Chabance B, Marteau P, Rambaud J C, Migliore-Samour D, Jollès P, Boynard M, Perrotin P, Guillet R and Fiat A M (1998) Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80 155-165.
8. Cheung H-S, Feng-Lai W, Ondetti M A, Sabo E F and Cushman D W (1980) Binding of peptide substrates and inhibitors of angiotensin-converting-enzyme. Journal of Biological Chemistry 255 401-407.
9. Chiba H and Yoshikawa M (1986) Biologically functional peptides from food proteins: new opioid peptides from milk proteins. In Protein Tailoring for Food and Medical Uses, pp 123-153. Feeney R E and Whitaker J, eds. New York: Marcel Dekker.
10. Chiba H and Yoshikawa M (1991) Bioactive peptides derived from food proteins. Kagaku to Seibutsu 29 454-458.
11. Chiba H, Tani F and Yoshikawa M (1989) Opioid antagonist peptides derived from kappa-casein. Journal of Dairy Research 56 363-366.
12. Clare D A and Swaisgood H E (2000) Bioactive milk peptides: a prospectus. Journal of Dairy Science 83 1187-1195.
13. Coste M, Rochet V, Lèonil J, Mollè D, Bouhallab S and Tomè D (1992) Identification of C-terminal peptides of bovine β-casein that enhance proliferation of rat lymphocytes. Immunology Letters 33 41-46.
14. Devin D A and Hancock R E W (2002) Cationic peptides distribution and mechanism of resistance. Current Pharmaceutical Design 8 703-714.
15. Dionysius D A and Milne J M (1997) Antibacterial peptides of bovine lactoferrin: purification and characterization. Journal of Dairy Science 80 667-674.
16. Dziuba J, Minkiewicz P, Nalecz D and Iwaniak A (1999) Database of biologically active peptide sequences. Die Nahrung 43 190-195.
17. Epand R C and Vogel H J (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochimica et Biophysica Acta 1462 11-28.
18. Ferreira S H, Bartet D C and Greene L J (1970) Isolation of bradykinin-potentiating peptides from Bothropsjararaca venom. Biochemistry 9 2583-2593.
19. Fiat A M, Migliore-Samour D, Jollès P, Drouet L, Sollier C B D and Caen J (1993) Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. Journal of Dairy Science 76 301-310.
20. FitzGerald R J (1998) Potential uses of caseinophosphopeptides. International Dairy Journal 8 451-457.
21. FitzGerald R J and Meisel H (2000) Milk protein derived peptide inhibitors of angiotensin-I-converting enzyme. The British Journal of Nutrition 84 S33-S37.
22. Floris R, Recio I, Berkhout B and Visser S (2003) Antibacterial and antiviral effects of milk proteins and derivatives thereof. Current Pharmaceutical Design 9 1257-1273.
23. Fuglsang A, Rattray F P, Nilsson D and Nyborg N C B (2003) Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie Van Leeuwenhoek 87 27-34.
24. Gill H S, Doull F, Rutherfurd K J and Cross M L (2000) Immunoregulatory peptides in bovine milk. British Journal of Nutrition 58 111-117.
25. Ginger M R and Grigor M R (1999) Comparative aspects of milk caseins. Comparative Biochemistry and Physiology 124, 133-145.
26. Gobbetti M, Ferranti P, Smacchi E, Goffredi F and Addeo F (2000) Production of angiotensin-I converting enzyme (ACE)-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied and Environmental Microbiology 66, 3898-3904.
27. Gobbetti M, Stepaniak L, De Angelis M, Corsetti A and Di Cagno R (2002) Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Critical Reviews in Food Science Nutrition 42 223-239.
28. Groenink J, Walgreen-Weterings E, Van't Hof W, Veerman E C I and van Nieuw Amerongen A (1999) Cationic amphipathic peptides derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiology Letters 179 217-222.
29. Haileselassie S, Lee B H and Gibbs B F (1999) Purification and identification of potentially bioactive peptides from enzyme-modified cheese. Journal of Dairy Science 82 1612-1627.
30. Hancock R E W and Leher R (1998) Cationic peptides: a new source of antibiotics. Trends in Biotechnology 16 82-88.
31. s1-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte cultures. Journal of Dairy Research 65 569-578.
32. Hata I, Ueda J and Otani H (1999) Immunostimulatory action of a commercially available casein phosphopeptide preparation, CPP-III, in cell culture. Milchwissenschaft 54 3-7.
33. Hata Y, Yamamoto M, Ohni H, Nakajima K, Nakamura Y and Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 64 767-771.
34. Hill R D, Lahov E and Givol D (1974) A rennin-sensitive bond in alpha and beta casein. Journal of Dairy Research 41 147-153.
35. Hoek H S, Milne J M, Greve P A, Dionysius D A and Smith R (1997) Antibacterial activity in bovine lactoferrin-derived peptides. Antimicrobial Agents and Chemotherapy 41 54-59.
36. Ibrahim H R, Thomas U and Pellegrini A (2001) A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. Journal of Biological Chemistry 276 43767-43774.
37. Jollès P and Henschen A (1982) Comparison between the clotting of blood and milk. Trends in Biochemical Sciences 7 325-330.
38. Jollès P, Loucheux-Lefebvre M-H and Henschen A (1978) Structural relatedness of ε-casein and fibrinogen 8-chain. Journal of Molecular Evolution 11 271-277.
39. Jollès P, Levy-Toledano S, Fiat A M, Soria C, Gillensen D, Thomaidis A, Dunn F W and Caen J (1986) Analogy between fibrinogen and casein: effect of an undecapeptide isolated from κ-casein on platelet function. European Journal of Biochemistry 158 379-382.
40. Jones E M, Smart A, Bloomberg G, Burgess L and Millar M R (1994) Lactoferricin, a new antimicrobial peptide. Journal of Applied Bacteriology 77 208-214.
41. Jones F S and Simms H S (1930) The bacterial growth inhibitor (lactenin) of milk. Journal of Experimental Medicine 51 327-339.
42. Kayser H and Meisel H (1996) Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Letters 383 18-20.
43. Lahov E and Regelson W (1996) Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food and Chemical Toxicology 34 131-145.
44. Lahov E, Edelsten D, Sode-Morgensen M T and Sofer E (1971) Properties of basic glycopeptides released from cow milk protein by heat. Milchwissenschaft 26 489-495.
45. Liepke C, Zucht H D, Forsmann W G and Standker L (2001) Purification of novel peptide antibiotics from human milk. Journal of Chromatography 752 369-377.
46. Loukas S, Varoucha D, Zioudrou C, Streaty R A and Klee W A (1983) Opioid activities and structures of α-casein-derived exorphins. Biochemistry 22 4567-4573.
47. MacDonald R S, Thornton W H and Marshall R T (1994) A cell culture model to identify biologically active peptides generated by bacterial hydrolysis of casein. Journal of Dairy Science 77 1167-1175.
48. Maeno M, Yamamoto N and Takano T (1996) Isolation of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. Journal of Dairy Science 79 1316-1321.
49. Malkoski M, Dashper S G, O'Brien-Simpson N M, Talbo G H, Macris M and Cross K J (2001) Kappacin, a novel antibacterial peptide from bovine milk. Antimicrobial Agents and Chemotherapy 45 2309-2315.
50. Maruyama S and Suzuki H (1993) A peptide inhibitor of angiotensin-I-converting enzyme in the tryptic hydrolysate of casein. Agricultural and Biological Chemistry 46 393-1394.
51. s1-casein. Agricultural and Biological Chemistry 51 2557-2561.
52. Maruyama S, Mitachi H, Tanaka H, Tomizuka N and Suzuki H (1987b) Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein. Agricultural and Biological Chemistry 51 1581-1586.
53. Maruyama S, Nakagomi K, Tomizuka N and Suzuki H (1985) Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agricultural and Biological Chemistry 49 1405-1409.
54. Meisel H (1986) Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Letters 196 223-227.
55. Meisel H (1993) Casokinins as inhibitors of angiotensin-converting-enzyme. In New Perspectives in Infant Nutrition, pp 153-159. Sawatzki G and Renner B, eds. New York: Thieme.
56. Meisel H (1997) Biochemical properties of bioactive peptides derived from milk proteins: potential nutraceuticals for food and pharmaceutical applications. Livestock Production Science 50 125-138.
57. Meisel H (2001) Bioactive peptides from milk proteins: a perspective for consumers and producers. Australian Journal of Dairy Technology 56 83-91.
58. Meisel H and Frister H (1988) Isolation and characterization of a phosphopeptide from in vivo digests of casein. In Milk Proteins Nutritional, Chemical, Functional and Technological Aspects, pp 150-154. Barth C A and Schlimme E, eds. Darmstadt: Steinkopf Verlag.
59. Meisel H and Günther S (1998) Food proteins as precursor of peptides modulating human cell activity. Nahrung/Food 42 175-176.
60. Meisel H and Olieman C (1998) Estimation of calcium-binding constants of casein phosphopeptides by capillary zone electrophoresis. Analytica Chimica Acta 372 291-297.
61. Meisel H and Schlimme E (1990) Milk proteins: precursors of bioactive peptides. Trends in Food Science and Technology 1 41-43.
62. Meisel H and Schlimme E (1994) Inhibitors of angiotensin-converting-enzyme derived from bovine casein (casokinins). In β-Casomorphins and Related Peptides: Recent Developments, pp 27-33. Brantl V and Teschemacher H, eds. Weinheim: VCH.
63. Meisel H, Frister H and Schlimme E (1989) Biologically active peptides in milk proteins. Zeitscrift für Ernharung 28 267-278.
64. Meisel H, Goepfert A and Günther S (1997) ACE inhibitory activities in milk products. Milchwissenschaft 52 307-311.
65. Meisel H, Günther S, Martin D and Schlimme E (1998) Apoptosis induced by modified ribonucleosides in human cell culture systems. FEBS Letters 433 265-268.
66. Migliore-Samour D, Floc'h F and Jollès P (1989) Biologically active casein peptides implicated in immunomodulation. Journal of Dairy Research 56 357-362.
67. Minervini F, Algaron F, Rizzello C G, Fox P F, Monnet V and Gobbetti M (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Applied and Environmental Microbiology 69 5297-5305.
68. Mullally M, Meisel H and FitzGerald R J (1996) Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biological Chemistry Hoppe-Seyler 377 259-260.
69. Mullally M, Meisel H and FitzGerald R J (1997) Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic digest of bovine β-lactoglobulin. FEBS Letters 402 99-101.
70. Nagaune S, Azuma N, Ishino Y, Mori H, Kaminogawa S and Yamauchi K (1989) DNA-synthesis stimulating peptide from bovine β-casein. Agricultural and Biological Chemistry 53 3275-3278.
71. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S and Takano T (1995) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 78 777-783.
72. Pellegrini A, Thomas U, Bramaz N, Hunziker P and von Fellenberg R (1999) Isolation and identification of three bactericidal domains in the bovine alpha-lactalbumin molecule. Biochimica et Biophysica Acta 1426 439-448.
73. Pellegrini A, Dettling C, Thomas U and Hunziker P (2001) Isolation and characterization of four bactericidal domains in the bovine β -lactoglobulin. Biochimica et Biophysica Acta 1526 131-140.
74. Petrillo E W Jr and Ondetti M A (1982) Angiotensin converting enzyme inhibitors: medicinal chemistry and biological actions. Medicinal Research Reviews 2 1-41.
75. Pihlanto-Leppälä A (2001) Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends in Food Science and Technology 11 347-356.
76. Pihlanto-Leppälä A, Rokka T and Korhonen H (1998) Angiotensin I converting enzyme inhibitory peptides from bovine milk proteins. International Dairy Journal 8 325-331.
77. Quian S Y, Jollès P, Migliore-Samour D and Fiat A M (1995) Isolation and characterization of sheep lactoferrin, in an inhibitor of platelet aggregation and comparison with human lactoferrin. Biochimica et Biophysica Acta 1243 25-32.
78. Recio I and Visser S (1999) Identification of two distinct antibacterial domains within the sequence of bovine alpha(s2)-casein. Biochimica et Biophysica Acta 1428 314-326.
79. Recio I and Visser S (2000) Antibacterial and binding characteristics of bovine, ovine and caprine lactoferrins: a comparative study. International Dairy Journal 10 597-605.
80. Reynolds E C, Cain C J, Webber F L, Black C L, Riley P F, Johnson I H and Perich J W (1995) Anticariogenicity of calcium phosphate complexes of tryptic caseinophosphopeptides in the rat. Journal of Dental Research 74 1272-1279.
81. Rokka T, Syvoja E L, Tuominen J and Korhonen H (1997) Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk. Milchwissenschaft 52 675-678.
82. Ryhänen E-L, Pihlanto-Leppala A and Pahkala E (2001) A new type of ripened, low-fat cheese with bioactive properties. International Dairy Journal 11 441-447.
83. Schanbacher F L, Talhouk R S, Murray F A, Gherman L I and Willet L B (1998) Milk-borne bioactive peptides. International Dairy Journal 8 393-403.
84. Schlimme E and Meisel H (1995) Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Die Nahrung 39 1-20.
85. Schlimme E, Meisel H and Frister H (1988) Bioactive sequences in milk proteins. In Milk Proteins: Nutritional, Clinical, Functional and Technological Aspects, pp 143-149. Barth C A and Schlimme E, eds. New York: Springer.
86. Shinoda I, Takase M, Fukuwatari Y, Shimamura S, Koller M and Konig W (1996) Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leukocytes. Bioscience, Biotechnology, and Biochemistry 60 521-523.
87. Smacchi E and Gobbetti M (1998) Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme and Microbial Technology 22 687-694.
88. Stepaniak L, Fox P F, Sørhaug T and Grabska J J (1995) Effect of peptides from the sequence 58-72 of β-casein on the activity of endopeptidase, aminopeptidase and X-prolyldipeptidyl aminopeptidase from Lactococcus. Journal of Agricultural and Food Chemistry 45 849-853.
89. Stromqvist M, Falk P, Bergstrom S, Hansson L, Lonnerdal B, Normark S and Hernell O (1995) Human milk kappa-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. Journal of Pediatric Gastroenterology and Nutrition 21 288-296.
90. Tani F, Shiota A, Chiba H and Yoshikawa M (1994) Serorphin, an opioid peptide derived from bovine serum albumin. In β-Casomorphins and Related Peptides: Recent Developments, pp 49-53. Brantl V and Teschemacher H, eds. Weinheim: VCH.
91. Vegarud G E, Langsrud T and Svenning C (2000) Mineral-binding milk proteins and peptides; occurrence, biochemical and technological characteristics. British Journal of Nutrition 58 91-98.
92. Vorland L H, Ulvatne H, Andersen J, Haukland H H, Rekdal Ø, Svendsen J S and Gutteberg T J (1998) Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scandinavian Journal of Infectious Diseases 30 513.
93. Walker J R, Roth J R and Altman E (2001) An in vivo study of novel bioactive peptides that inhibit the growth of Escherichia coli. Journal of Peptide Research 58 380-388.
94. Wieprecht T, Dathe M, Epand R M, Beyermann M, Krause E, Maloy W L, MacDonald D L and Bienert M (1997) Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry 36 12869-12880.
95. Yamamoto N (1997) Antihypertensive peptides derived from food proteins. Biopolymers 43 129-134.
96. Yamamoto N, Akino A and Takano T (1994a) Antihypertensive effect of different kinds of fermented milk in spontaneously hypertensive rats. Bioscience, Biotechnology, and Biochemistry 58 776-778.
97. Yamamoto N, Akino A and Takano T (1994b) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. Journal of Dairy Science 77 917-922.
98. Yamamoto N, Maeno M and Takano T (1999) Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. Journal of Dairy Science 82 1388-1393.
99. Yamauchi K, Tomita M, Giehl T J and Ellison R T III (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infection and Immunity 61 719-728.
100. s1-casein. In β-Casomorphins and Related Peptides: Recent Developments, pp 43-48. Brantl V and Teschemacher H, eds. Weinheim: VCH.
101. s2 derived peptide exhibits antibacterial activity. FEBS Letters 372 185-188.